Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016 (2016), Article ID 3631764, 13 pages
http://dx.doi.org/10.1155/2016/3631764
Review Article

Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies

1Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, London WC2A 3LY, UK
2Central University Hospital of Asturias (HUCA) and Institute of Oncology of Asturias (IUOPA), 33011 Oviedo, Spain
3Complutense University of Madrid, 28040 Madrid, Spain
4Orthopaedic Pathophysiology and Regenerative Medicine Unit, Rizzoli Orthopaedic Institute, 40136 Bologna, Italy
5Department of Biomedical and Neuromotor Sciences, University of Bologna, 40123 Bologna, Italy
6Cellular Biotechnology Laboratory, Institute of Health Carlos III (ISCIII), Majadahonda, 28220 Madrid, Spain

Received 7 January 2016; Accepted 10 May 2016

Academic Editor: Andrzej Lange

Copyright © 2016 Ander Abarrategi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ander Abarrategi, Juan Tornin, Lucia Martinez-Cruzado, et al., “Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies,” Stem Cells International, vol. 2016, Article ID 3631764, 13 pages, 2016. doi:10.1155/2016/3631764